HOCHDORF processed 218.9 million kg of milk, cream, whey etc. (PY: 187.9 million kg) in Switzerland and sold 32,356 tonnes of products (PY: 46,357 tonnes). This resulted in net sales revenue of CHF 140.3 million (PY: 158.3 million), EBITDA of CHF –2.8 million and EBIT of CHF –8.6 million.

HOCHDORF expects a stronger second half-year, benefiting from higher order intake and better capacity utilisation in the Baby Care division, as well as a seasonal reduction in inventories. Accordingly, EBIT should improve significantly in the second half of the year and result in a balanced result at EBIT level for the 2021 business year, as previously announced. The forecast for net sales also remains unchanged at CHF 260 to 300 million.

HOCHDORF was reorganised as of 01.01.2021 in accordance with the strategic foundations created in 2020 and Bimbosan AG was successfully integrated into HOCHDORF Swiss Nutrition Ltd. Despite the restrictions caused by the coronavirus pandemic, new customers and markets were acquired and new products were successfully launched in Switzerland and abroad. HOCHDORF has received the purchase price repayment from Pharmalys and has contractually agreed the future strategic cooperation with its largest customer in the Baby Care division.

Despite the successful strategic restructuring and operational focus, the HOCHDORF Group’s economic situation remains challenging. The Group Management and the Board of Directors are therefore examining further measures to stabilise the company's balance sheet.